The first clinical data of the SAPIEN 3 aortic valve in the treatment of aortic stenosis in China

BACKGROUND: Data on outcomes following transcatheter aortic valve replacement with SAPIEN 3 in China is limited as it was approved by the National Medical Products since 2020. The present study was designed to collect clinical data on the SAPIEN 3 aortic valve in Chinese patients with bicuspid aorti...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Xiaoke, Pan, Xiangbin, Zhang, Gejun, Jiang, Zhengming, Liu, Xianbao, Song, Guangyuan, Li, Yi, Wang, Yan, Luo, Jianfang, Tang, Yida, Yuan, Yiqiang, Wu, Yongjian, Ma, Xiang, Zhu, Dan, Zhong, Yucheng, Zhang, Changdong, Dong, Nianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293831/
https://www.ncbi.nlm.nih.gov/pubmed/37383702
http://dx.doi.org/10.3389/fcvm.2023.1064255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293831/
https://www.ncbi.nlm.nih.gov/pubmed/37383702
http://dx.doi.org/10.3389/fcvm.2023.1064255

Ejemplares similares